Mikhail Blagosklonny Speaks on Immunity Rejuvenation Using Anti-Aging Drugs

Mikhail Blagosklonny is an oncology scientist at Roswell Park Cancer Institute. He majors in the study of cancer and aging. His research interest features biogerontology, a study that dwells on the mechanisms of aging, effective anti-aging drugs, the prevalence of diseases among the aged and possible therapies that improve the quality of healthy body cells and how to avoid cell damage.

Mikhail earned his MD in internal medicine from First Pavlov State Medical University in St. Petersburg. He proceeded to earn a Ph.D. in experimental medicine and cardiology from the same institution. After his studies, Mikhail joined New York Medical College as an associate professor and later joined Ordway Research Institute as a senior scientist. He joined Roswell Park Institute as a professor of oncology in 2009. Mikhail is among the best and outstanding cancer researchers today with a rich, expansive experience in the field. Read more about Mikhail at LinkedIn

In his contribution to the Oncortarget, Mikhail Blagosklonny provides insight on how rejuvenation of body cells can help reduce the prevalence of cancer among the aged. In the article, he breaks the old myth that aging is a process resulting from continued molecular damage. He produced the TOR signaling possible hypothesis that defines the relationship between cancer and aging. From these findings, he proposes the use of a popular cancer treatment drug, Rapamycin. In his findings, he describes aging as a continuation of growth. Oncotarget is a medical journal that accepts contributions in areas related to cancer diagnosis, treatment, and management. It is a platform where oncologists, medical practitioners, and patients make contributions on various available modalities as well as new research findings.

Through the use of Rapamycin, Mikhail Blagosklonny asserts that it is possible to reduce the aging effect on humans and in the process increase the body’s immunity. Researchers have over the years given varying results on the use of anti-aging produces in cancer management. Results from research volunteers indicate varying results on different individuals. However, with the application of various newfound models, use of anti-aging drugs has proved to be an effective method to increase the body’s immunity. With the new findings, concerns continue to rise on the probable time of death with the anti-aging effect. On this, Mikhail’s article notes that there is sure to be an emergence of new unknown causes of death hence humans cannot beat immortality even with scientific advancements.

Mikhail Blagosklonny believes in the possibility of controlling aging and cancer. He further believes that through this control, there is a possibility of effective treatment of cancer through the use of the anti-aging drug, Rapamycin. With this belief, Mikhail has numerous articles, books, and chapters published under his name on different platforms. His contribution extends further as an editor in some leading medical publications. Visit ResearchGate to know more about Mikhail’s latest work.